Clinical Trials Sponsored by IRCAD - EITS

Total 119 results

Azienda Ospedaliera Città della Salute e della...
IRCAD - EITS

Completed

Effects of Warmed, Humidified CO2 Insufflation on Body Core Temperature and Cytokine Response

Hypothermia

Italy
IHU Strasbourg
IRCAD

Unknown

Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass

Morbid Obesity

France
Taipei Medical University Shuang Ho Hospital
IRCAD-Taiwan

Completed

Stepwise Training Program

Laparoscopic Suturing

Taiwan
Xoft, Inc.
Icad, Inc.

Recruiting

Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (IORT)

Glioblastoma | GBM | Recurrent Glioblastoma | Recurrent GBM

United States
Xoft, Inc.
Icad, Inc.

Active, not recruiting

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

Ductal Carcinoma in Situ | Invasive Ductal Carcinoma

United States, Portugal, Australia
Xoft, Inc.
Icad, Inc.

Completed

Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer

Cervical Cancer

United States
SITS International

Unknown

Reduction of In-hospital Delays in Stroke Thrombolysis: SITS-WATCH (SITS-WATCH)

Stroke

Sweden
Xoft, Inc.
Icad, Inc.

Withdrawn

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

Ductal Carcinoma In Situ | Invasive Ductal Carcinoma
GCS IHFB Cognacq-Jay
Fondation ARCAD

Active, not recruiting

TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study. (TWICE-IRI)

Metastasis | Cancer Colorectal

France
Federation Francophone de Cancerologie Digestive
Fondation ARCAD

Recruiting

Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA (KANALRAD)

Anal Cancer

France
GERCOR - Multidisciplinary Oncology Cooperative...
Fondation ARCAD

Recruiting

Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas (NEONEC)

Neuroendocrine Carcinoma | Digestive Cancer

France
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Primary Cardiac Lymphoma: Italian Multicenter Experience

Primary Cardiac Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Recruiting

Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial (FIL_FOLL-BIO)

Follicular Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Recruiting

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

Low Grade Non-Hodgkin's Lymphoma, Adult

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

Lymphoma | Large B-Cell | Diffuse Large B-Cell

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial (FIL-RougeBIO)

Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma (FIL_MOGA)

Cutaneous T Cell Lymphoma | Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Cutaneous T-Cell Lymphoma/Sezary Syndrome

Italy
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance (FIL_FollVax22)

Follicular Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy (FIL_Tisle-HL)

Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Recruiting

Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma

Follicular Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS (FIL_BIOWM)

Waldenstrom Macroglobulinemia

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Relapsed Follicular Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Terminated

Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lymphoma

T-Cell Lymphoma Relapsed | T-Cell Lymphoma Refractory

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas (FIL_PTCL13)

Peripheral T-cell Lymphomas (PTCL) | PTCL-NOS | Angioimmunoblastic T-cell Lymphoma (AITL) | ALK- Anaplastic Large Cell Lymphoma (ALCL) | Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients (FIL_RENOIR12)

Lymphoma, Follicular

Italy
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

Classical Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma (DLBCL)

Italy
Fondazione Italiana Linfomi - ETS

Recruiting

Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. (FIL_COLUMN)

Refractory Mantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Recruiting

Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

Mantle Cell Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

The Role of 18F-FDG-PET for Staging and Prognostication

Mantle Cell Lymphoma

Portugal, Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Indolent Non Follicular Lymphomas Prognostic Project

Indolent B-Cell Lymphomas

France, Italy, Brazil, Austria, Portugal, Ukraine
Fondazione Italiana Linfomi - ETS

Terminated

Idelalisib+Obinutuzumab in Patients With Relapsed/Refractory Follicular Lymphoma (GAUDEALIS)

Follicular Lymphoma

Italy
Aberystwyth University
EIT Health

Unknown

FrAilty Care and wEll-funcTion in Community Dwelling Older Adults (FACET)

Frailty | Sarcopenia | Aging

United Kingdom
Ever Neuro Pharma GmbH
SITS International

Terminated

Cerebrolysin REGistry Study in Stroke (CREGS-S)

Ischemic Stroke

Austria
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Completed

Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy (BIOFER12)

Myelofibrosis | Aplastic Anemia | Myelodysplasia

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Withdrawn

Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes (CLO2009AISSM05)

Myelodysplastic Syndromes

Italy
Sir Mortimer B. Davis - Jewish General Hospital
Icad, Inc.

Recruiting

Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy (Whistle)

Rectal Cancer | Inoperable Disease | Comorbidities and Coexisting Conditions | Brachytherapy

Canada
Wits Health Consortium (Pty) Ltd
Discovery Vitality

Active, not recruiting

The Vitality Mammography Messaging Study (VMS)

Breast Cancer Female

South Africa
Wits Health Consortium (Pty) Ltd
Discovery Vitality

Active, not recruiting

Testing the Effectiveness of Different Messaging Approaches to Increase Doctor Visits Amongst Individuals With Risk Factors for Diabetes

Type 2 Diabetes | Pre-diabetes

South Africa
ANRS, Emerging Infectious Diseases
UMR 1252 SESSTIM; ARCAD Santé PLUS; SEREFO

Unknown

ANRS 12392 Sanu Gundo (SANU GUNDO)

HIV Infections

Mali
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Recruiting

Italian Network MDS Registry (FISM_registry)

Myelodysplastic-Myeloproliferative Diseases

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Terminated

Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS

Myelodysplastic Syndromes

Italy
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Recruiting

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care (FISiM-NGS-MDS)

MDS (Myelodysplastic Syndrome)

Italy
University Hospital, Bordeaux
EIT Health

Active, not recruiting

Computed Tomography-Guided Catheter Ablation for Ventricular Tachycardia (InEurHeart)

Ventricular Tachycardia

France, Germany, Switzerland, Austria
Fondazione Italiana Linfomi - ETS
AbbVie

Active, not recruiting

Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL

Lymphoma, Mantle-Cell

Italy
Inossia AB
Uppsala University; EIT Health

Recruiting

Investigating Bone Cement With or Without Inossia™ Cement Softener for Vertebral Compression Fractures (SOFTBONE)

Vertebral Compression Fracture

Spain, Germany, Canada, Poland
Fondazione Ricerca e Innovazione Cardiovascolare...

Recruiting

Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels (TRANSFORM II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Netherlands, Italy, France, Bangladesh
Indiana University
Health Information Technology Solutions (HITS) LLC

Withdrawn

M-Health for Teen Substance Abuse and Mental Illness Pilot

Mental Health Disorder | Post Traumatic Stress Disorder | Substance Use Disorders | Adolescent Behavior

Clinical Trials Sponsored by IRCAD - EITS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations